“The digital pathology market is projected to grow at a CAGR of 13.8% during the forecast period (2020–2025).”
The global digital pathology market is projected to reach USD 1,054 million by 2025 from USD 553 million in 2020, at a CAGR of 13.8% during the forecast period. The key factors driving the growth of this market include the
increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.
“Adoption of artificial intelligence is expected to increase during the forecast period.”
The adop......
|
$4950 |
|
Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus
Summary
GlobalData, the industry analysis specialist, has released its latest report: "Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-hous......
|
$1995 |
|
The pharmaceutical packaging equipment market is expected to grow at a CAGR of 7.4% in the forecast period.
The global pharmaceutical packaging equipment market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025. The growth of the market is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible & integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, and the introduction of regulatory standards on packaging & stringent norms against counterfeiting. However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a cer......
|
$4950 |
|
Central Retinal Vein Occlusion Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Central Retinal Vein Occlusion Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Central Retinal Vein Occlusion Clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated us......
|
$2500 |
|
Malignant Pleural Effusion Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Malignant Pleural Effusion Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Malignant Pleural Effusion Clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Pleural Effusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
|
$2500 |
|
Primary Immune Deficiency (PID) Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Primary Immune Deficiency (PID) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Primary Immune Deficiency (PID) Clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Immune Deficiency (PID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generate......
|
$2500 |
|
Rabies Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Rabies Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Rabies Clinical trials scenario. This report provides top line data relating to the clinical trials on Rabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are c......
|
$2500 |
|
House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of House Dust Mite Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary......
|
$2500 |
|
Measles Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Measles Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Measles Clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials a......
|
$2500 |
|
Menorrhagia Disease - Global Clinical Trials Review, H2, 2020
Summary
GlobalData's clinical trial report, "Menorrhagia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Menorrhagia Clinical trials scenario. This report provides top line data relating to the clinical trials on Menorrhagia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. C......
|
$2500 |
|
